Controlling drug-to-antibody ratio and scalable reactors are key to reliable antibody-drug conjugate manufacturing success.

After five years of unprecedented momentum, the ADC field now finds itself at an interesting inflection point. With more programs in development and greater industry prioritization than ever before, ...

French drugmaker Sanofi has halted the development of its antibody-drug conjugate (ADC) tusamitamab ravtansine after the drug failed a phase 3 trial in non-small cell lung cancer (NSCLC). The drug, ...

GHz phased array radar system featuring Pulse Linear Frequency Modulated (LFM) modulation and based on an AMD Artix-7 FPGA. Two versions are available: the AERIS-10N (Nexus), providing up to 3km range ...

Remember those brick cellphones in the 1990s? They were comically large by today’s standards. These phones used the 1G ...